IRIS

Thallium acetate

CASRN 563-68-8

The assessment summary for thallium acetate is based on the Toxicological Review for Thallium (I), Soluble Salts (see related topics).

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (17 pp, 137 K) last updated: 09/30/2009
Information reviewed but value not estimated.

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (17 pp, 137 K) last updated: 09/30/2009
Information reviewed but value not estimated.

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (17 pp, 137 K) last updated: 09/30/2009

WOE Characterization Framework for WOE Characterization
Inadequate information to assess carcinogenic potential Guidelines for Carcinogen Risk Assessment (US EPA, 2005)
Basis:
  • Under the Guidelines for Carcinogen Risk Assessment (U.S. EPA, 2005a), the database for thallium and compounds provides "inadequate information to assess carcinogenic potential."
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (17 pp, 137 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (17 pp, 137 K)

Not assessed under the IRIS Program.


Error Occured Invoking Component (CAS: 563-68-8) - Example for format checks only
Component error: Error Executing Database Query.

2002: IRIS TOXICOLOGICAL REVIEW OF BENZENE (NONCANCER EFFECTS)

1998: IRIS TOXICOLOGICAL REVIEW OF BENZENE (NONCANCER EFFECTS) (EXTERNAL REVIEW DRAFT)

1999: Test link

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.